Dana-Farber Cancer Institute, Harvard Medical School

Boston, Massachusetts 02215

1 studies enrolling now · 4 studies all time

What they study most

Glioblastoma, Metastatic Breast Cancer, Refractory Multiple Myeloma, Relapse Multiple Myeloma, Sarcoma

Studies at this site

• Efficacy of Trastuzumab Deruxtecan in Metastatic Breast Cancer With Different HER2 Expression Patterns — Recruiting now
• MMRC Horizon One: RRMM (MMRC-099) — Running, not enrolling
• Molecular Genetic, Host-derived and Clinical Determinants of Long-term Survival in Glioblastoma — Completed
• Surgery With or Without Radiation Therapy in Untreated Nonmetastatic Retroperitoneal Sarcoma — Completed